Evidence map›Paper›PMID 11678599›Full record

ArticleMolecular and cellular biochemistry2001

Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest.

T O'Brien, J Xu, S R Patierno

Abstract read
PubMed
In one paragraph

Article in Molecular and cellular biochemistry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Chemical mechanisms of DNA damage by carcinogenic chromium(VI).Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  4. Food safety of the green tiger shrimp Penaeus semisulcatus from the Persian Gulf.Environmental science and pollution research international · 2022
    Article
  5. Article
  6. Article
  7. Treatment of Wastewater Using Seaweed: A Review.International journal of environmental research and public health · 2018
    Review
  8. Article
  9. Environmental exposure to arsenic and chromium in an industrial area.Environmental science and pollution research international · 2017
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

T O'BrienDepartment of Pharmacology, The George Washington University Medical Center, Washington, DC 20037, USA.
J Xu
S R Patierno
George Washington University · USUnited States Military Academy · USWashington University Medical Center · US

Funding

PARTICULATE CHROMIUM TOXICITY AND CARCINOGENESISR01ES005304 · NIEHS · GEORGE WASHINGTON UNIVERSITY · PI PATIERNO, STEVEN R · 1990 to 2007
$2.6M
NIEHS NIH HHS R01-ES-05304
6 · The paper itself

Abstract

Hexavalent chromium (Cr (VI)) is reduced intracellularly to Cr (V), Cr (IV) and Cr (III) by ascorbate (Asc), cysteine and glutathione (GSH). These metabolites induce a spectrum of genomic DNA damage resulting in the inhibition of DNA replication. Our previous studies have shown that treatment of DNA with Cr (III) or Cr (VI) plus Asc results in the formation of DNA-Cr-DNA crosslinks (Cr-DDC) and guanine-specific arrests of both prokaryotic and mammalian DNA polymerases. GSH not only acts as a reductant of Cr (VI) but also becomes crosslinked to DNA by Cr, thus, the focus of the present study was to examine the role of GSH in Cr-induced DNA damage and polymerase arrests. Co-incubation of Cr (III) with plasmid DNA in the presence of GSH led to the crosslinking of GSH to DNA. GSH co-treatment with Cr (III) also led to a decrease in the degree of Cr-induced DNA interstrand crosslinks relative to Cr (III) alone, without affecting total Cr DNA binding. DNA polymerase arrests were observed following treatment of DNA with Cr (III) alone, but were markedly reduced when GSH was added to the reaction mixture. Pre-formed polymerase-arresting lesions (Cr-DDC) were not removed by subsequent addition of GSH. Treatment of DNA with Cr (VI), in the presence of GSH, resulted in crosslinking of GSH to DNA, but failed to produce detectable DNA interstrand crosslinks or polymerase arrests. The inhibitory effect of GSH on Cr-induced polymerase arrest was further confirmed in human genomic DNA using quantitative PCR (QPCR) analysis. Treatment of genomic DNA with Cr (III) resulted in a marked inhibition of the amplification of a 1.6 kb target fragment of the p53 gene by Taq polymerase. This was almost completely prevented by co-treatment with GSH and Cr (III). These results indicate that Cr-induced DNA interstrand crosslinks, and not DNA-Cr-GSH crosslinks, are the principal lesions responsible for blocking DNA replication. Moreover, the formation of DNA-Cr-GSH crosslinks may actually preclude the formation of the polymerase arresting lesions.

Indexed as

Binding SitesCell LineChromiumCross-Linking ReagentsDNADNA AdductsDNA DamageDNA-Directed DNA PolymeraseDNA ReplicationDrug InteractionsFibroblastsGenomeGlutathioneHumansLungOxidation-ReductionChromiumCross-Linking ReagentsDNADNA AdductsDNA-Directed DNA PolymeraseGlutathione

Identifiers

PMID11678599
OpenAlexW1555451663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.